Skip to the page

Data / Drug companies / XGen Pharmaceuticals DJB, Inc.

XGen Pharmaceuticals DJB, Inc.: 31 products in the FDA NDC directory, labeler code 39822

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

XGen Pharmaceuticals DJB, Inc. (labeler code 39822) lists 31 products in the FDA National Drug Code Directory, covering 23 finished drugs by generic name. By type: 31 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on April 7, 2026.

The request: Watch XGen Pharmaceuticals DJB, Inc. (FDA labeler code 39822): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
39822
Products in commercial distribution
31
Packages
34
Finished drugs by generic name
23
Prescription products
31
Over the counter products
0
Flagged as original packager
27 of 27 products that carry the flag
Started marketing in the last 12 months
3
Earliest marketing start
April 29, 1992
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)31100%

Products by type

TypeProductsShare
Prescription drugs31100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Injection, solution1238.7%
Injection, powder, lyophilized, for solution1032.3%
Solution412.9%
Injection26.5%
Injection, solution, concentrate13.2%
Inhalant13.2%
Injection, powder, for solution13.2%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Eribulin mesylate39822-2080InjectionGeneric drugs (ANDA)April 7, 2026
Vancomycin Hydrochloride39822-0470Injection, powder, lyophilized, for solutionGeneric drugs (ANDA)December 15, 2025
Vancomycin Hydrochloride39822-0460Injection, powder, lyophilized, for solutionGeneric drugs (ANDA)December 15, 2025
Olanzapine39822-1800Injection, powder, for solutionGeneric drugs (ANDA)August 28, 2025
Dehydrated Alcohol39822-9300Injection, solutionGeneric drugs (ANDA)June 24, 2025
Nelarabine39822-0650InjectionGeneric drugs (ANDA)February 17, 2025
Desmopressin Acetate39822-6250Injection, solutionGeneric drugs (ANDA)March 22, 2024
Desmopressin Acetate39822-6200Injection, solutionGeneric drugs (ANDA)March 22, 2024
Cyclophosphamide39822-0260Injection, powder, lyophilized, for solutionGeneric drugs (ANDA)December 19, 2023
Cyclophosphamide39822-0255Injection, powder, lyophilized, for solutionGeneric drugs (ANDA)December 19, 2023
Cyclophosphamide39822-0250Injection, powder, lyophilized, for solutionGeneric drugs (ANDA)December 19, 2023
Pentamidine Isethionate39822-3030InhalantGeneric drugs (ANDA)April 4, 2023
Folic Acid39822-1100Injection, solutionGeneric drugs (ANDA)November 17, 2019
Dactinomycin39822-2100Injection, powder, lyophilized, for solutionGeneric drugs (ANDA)July 31, 2019
Ibuprofen Lysine39822-1030SolutionGeneric drugs (ANDA)April 8, 2016
Lincomycin39822-0353Injection, solutionGeneric drugs (ANDA)July 5, 2015
Lincomycin39822-0350Injection, solutionGeneric drugs (ANDA)July 5, 2015
Promethazine hydrochloride39822-5550Injection, solutionGeneric drugs (ANDA)January 30, 2015
Promethazine hydrochloride39822-5525Injection, solutionGeneric drugs (ANDA)January 30, 2015
Clonidine39822-2010Injection, solutionGeneric drugs (ANDA)October 29, 2013
Clonidine39822-2000Injection, solutionGeneric drugs (ANDA)October 29, 2013
Rocuronium bromide39822-4200SolutionGeneric drugs (ANDA)December 1, 2012
Tranexamic Acid39822-1000Injection, solutionGeneric drugs (ANDA)May 18, 2012
Levetiracetam39822-4000Injection, solution, concentrateGeneric drugs (ANDA)August 5, 2011
Acetazolamide39822-0190Injection, powder, lyophilized, for solutionGeneric drugs (ANDA)December 10, 2008

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.